Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/113933
Title: | Authorised medicinal products produced using recombinant DNA technology |
Authors: | Manicaro, Nadia Serracino-Inglott, Anthony Sammut Bartolo, Nicolette |
Keywords: | Recombinant DNA Pharmaceutical industry -- Quality control Pharmaceutical technology Pharmaceutical technology -- Standards -- European Union countries |
Issue Date: | 2023 |
Citation: | N. Manicaro, A. Serracino-Inglott, & N. Sammut Bartolo (2023). Authorised medicinal products produced using recombinant DNA technology. Poster session at the International Pharmaceutical Federation 81st World Congress of Pharmacy, Brisbane, Australia. |
Abstract: | The use of genetically modified organisms and technologies such as recombinant DNA (rDNA) technology, enabled opportunities to produce new medicinal products. Along the years, numerous therapies were approved which address therapeutic needs. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/113933 |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Authorised_medicinal_products_produced_using_recombinant_DNA_technology(2023).pdf | 185.66 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.